This Saturday, February 4, we celebrate World Cancer Day. An important date in Belgium as the country has made the fight against cancer a national strategy which is bearing fruit. An idea ? According to the Cancer Foundation, 185,000 additional lives have been saved over the past 30 years. A success which, if…
Brussels (Belgium) – March 2, 2023 Quantoom Biosciences S.A. (“Quantoom”), a Belgian biotech with the mission to reinvent mRNA production announces today the opening of a brand-new facility in Évry-Courcouronnes (France). Following the SynHelix acquisition in 2021, Quantoom already had infrastructures in France, part of the Genopole campus, but these…
Damien Diop is replacing Marc Dechamps, former Director of International Affairs, currently CEO of Bioxodes Namur, Belgium, 20 February, 2023 – BioWin, the health cluster of Wallonia, announces today that Damien Diop, Head of Membership Development at BioWin, will also be in charge of international development, replacing Marc Dechamps. In…
Brussels, Liège, February 20, 2023. Vrije Universiteit Brussel (VUB) and its spin-off ABSCINT announce today that the United States Patent and Trademark Office (“USPTO”) has provided a Notice of Allowance for patent application No. 16/827,032, entitled “Radio-labelled antibody fragments for use in the prognosis and diagnosis of cancer as well as for the…
TRASIS closes a record year in 2022 with a +50% growth in sales. It invests for its future via the acquisition of ERAS LABO (Grenoble, France), a co-investment in the Belgian start-up ABSCINT (Ganshoren, Belgium) and adds 5,000m² to its current infrastructure. Ans, February 20, 2023. Trasis is increasingly establishing…
Brussels, the 2nd of February – Vivactis Group, the leading European healthcare consultancy group, announces its acquisition of Weber, a Market Access Consultancy firm and specialist in Health Economics and Outcomes Research (HEOR). The acquisition strengthens the Vivactis HM3A Market Access branch by expanding the reach in Market Access throughout…
On January 26th, the ground was officially broken for the expansion of the company Aseptic Technologies, located in the heart of the CREALYS science park in Gembloux-Les Isnes. Two new buildings with a total area of 2500m² as well as 460 solar panels will complete the existing premises. The new…
Cellaion SA announces a total fundraising of EUR 23 million in 2022 for its phase IIB study in Acute on Chronic Liver Failure with Truffle Capital as lead investor in the final Closing followed by Newton Biocapital, Wallonie Entreprendre and individual investors. Mont-Saint-Guibert, Belgium, 2023/01/13. Cellaïon is a biotechnology company…
La Belgique renforce sa position stratégique dans le secteur pharmaceutique grâce à un entrepôt ultramoderne MG Real Estate, Yusen Logistics Benelux et GSK posent le premier pilier d’un hub logistique de soins de santé avec traitement automatisé des commandes Gembloux, 20 décembre 2022 – MG Real Estate, Yusen Logistics et…
BioWin is moving its headquarters to Namur, right in the heart of Wallonia Our new address: Business Village Ecolys, Avenue d’Ecolys 2, 5020 Namur Effective: Monday, 2 January 2023 We are excited to announce that we are moving our headquarters to the Business Village Ecolys in Namur, right in the…
Business Village Ecolys
Avenue d’Ecolys 2
5020 Namur (Belgium)
Email : contact@biowin.org
VAT BE 0882.768.591
Website by Monkeys not Donkeys
© 2023 BioWin.
